Effect of a protein-free dialysate from calf blood on human monocyte differentiation in vitro

P. Spessotto, P. Dri, W. Baschong, H. Mittenzwei, P. Patriarca

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Solcoseryl® is a protein-free, standardized dialysate/ultrafiltrate derived from calf blood, which has been shown to improve situations of impaired healing in both experimental animals and man. Its activity seems to be multifactorial although the precise cellular and molecular mechanisms contributing to its effect have not been fully elucidated. Since monocyte-derived macrophages play a central role in inflammation and particularly in wound healing and tissue remodelling, the effect of the dialysate on human monocytes cultured in vitro for 10 days in the presence of human serum was studied. The results show that the drug, at concentrations ranging from 0.2 to 2%, increases the cell density of the cultures and the cell protein content, and favours the differentiation of monocytes into macrophages when 1% serum concentration is used in the culture medium. These effects are no more apparent when the serum concentration was raised to 10%. These data suggest that the drug may substitute, at least in part, for serum in monocyte-macrophage cultures. The observed effects give a sound basis for at least a partial explanation of the therapeutic effects of the drug, particularly at sites where the supply of serum-derived factors is limited.

Original languageEnglish
Pages (from-to)747-751
Number of pages5
JournalArzneimittel-Forschung/Drug Research
Volume43
Issue number7
Publication statusPublished - 1993

Fingerprint

Macrophages
Dialysis Solutions
Monocytes
Blood
Actihaemyl
Serum
Pharmaceutical Preparations
Proteins
Cell culture
Culture Media
Animals
Acoustic waves
Tissue
Therapeutic Uses
Wound Healing
Cell Culture Techniques
Cell Count
In Vitro Techniques
Inflammation

Keywords

  • hemodialysate, protein-free
  • macrophages
  • monocytes, differentiation, human
  • Solcoseryl®
  • wound healing drugs

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

Effect of a protein-free dialysate from calf blood on human monocyte differentiation in vitro. / Spessotto, P.; Dri, P.; Baschong, W.; Mittenzwei, H.; Patriarca, P.

In: Arzneimittel-Forschung/Drug Research, Vol. 43, No. 7, 1993, p. 747-751.

Research output: Contribution to journalArticle

Spessotto, P. ; Dri, P. ; Baschong, W. ; Mittenzwei, H. ; Patriarca, P. / Effect of a protein-free dialysate from calf blood on human monocyte differentiation in vitro. In: Arzneimittel-Forschung/Drug Research. 1993 ; Vol. 43, No. 7. pp. 747-751.
@article{97bc1ced20a9400a8a23e5f99ad663c0,
title = "Effect of a protein-free dialysate from calf blood on human monocyte differentiation in vitro",
abstract = "Solcoseryl{\circledR} is a protein-free, standardized dialysate/ultrafiltrate derived from calf blood, which has been shown to improve situations of impaired healing in both experimental animals and man. Its activity seems to be multifactorial although the precise cellular and molecular mechanisms contributing to its effect have not been fully elucidated. Since monocyte-derived macrophages play a central role in inflammation and particularly in wound healing and tissue remodelling, the effect of the dialysate on human monocytes cultured in vitro for 10 days in the presence of human serum was studied. The results show that the drug, at concentrations ranging from 0.2 to 2{\%}, increases the cell density of the cultures and the cell protein content, and favours the differentiation of monocytes into macrophages when 1{\%} serum concentration is used in the culture medium. These effects are no more apparent when the serum concentration was raised to 10{\%}. These data suggest that the drug may substitute, at least in part, for serum in monocyte-macrophage cultures. The observed effects give a sound basis for at least a partial explanation of the therapeutic effects of the drug, particularly at sites where the supply of serum-derived factors is limited.",
keywords = "hemodialysate, protein-free, macrophages, monocytes, differentiation, human, Solcoseryl{\circledR}, wound healing drugs",
author = "P. Spessotto and P. Dri and W. Baschong and H. Mittenzwei and P. Patriarca",
year = "1993",
language = "English",
volume = "43",
pages = "747--751",
journal = "Arzneimittel-Forschung/Drug Research",
issn = "0004-4172",
publisher = "Editio Cantor Verlag GmbH",
number = "7",

}

TY - JOUR

T1 - Effect of a protein-free dialysate from calf blood on human monocyte differentiation in vitro

AU - Spessotto, P.

AU - Dri, P.

AU - Baschong, W.

AU - Mittenzwei, H.

AU - Patriarca, P.

PY - 1993

Y1 - 1993

N2 - Solcoseryl® is a protein-free, standardized dialysate/ultrafiltrate derived from calf blood, which has been shown to improve situations of impaired healing in both experimental animals and man. Its activity seems to be multifactorial although the precise cellular and molecular mechanisms contributing to its effect have not been fully elucidated. Since monocyte-derived macrophages play a central role in inflammation and particularly in wound healing and tissue remodelling, the effect of the dialysate on human monocytes cultured in vitro for 10 days in the presence of human serum was studied. The results show that the drug, at concentrations ranging from 0.2 to 2%, increases the cell density of the cultures and the cell protein content, and favours the differentiation of monocytes into macrophages when 1% serum concentration is used in the culture medium. These effects are no more apparent when the serum concentration was raised to 10%. These data suggest that the drug may substitute, at least in part, for serum in monocyte-macrophage cultures. The observed effects give a sound basis for at least a partial explanation of the therapeutic effects of the drug, particularly at sites where the supply of serum-derived factors is limited.

AB - Solcoseryl® is a protein-free, standardized dialysate/ultrafiltrate derived from calf blood, which has been shown to improve situations of impaired healing in both experimental animals and man. Its activity seems to be multifactorial although the precise cellular and molecular mechanisms contributing to its effect have not been fully elucidated. Since monocyte-derived macrophages play a central role in inflammation and particularly in wound healing and tissue remodelling, the effect of the dialysate on human monocytes cultured in vitro for 10 days in the presence of human serum was studied. The results show that the drug, at concentrations ranging from 0.2 to 2%, increases the cell density of the cultures and the cell protein content, and favours the differentiation of monocytes into macrophages when 1% serum concentration is used in the culture medium. These effects are no more apparent when the serum concentration was raised to 10%. These data suggest that the drug may substitute, at least in part, for serum in monocyte-macrophage cultures. The observed effects give a sound basis for at least a partial explanation of the therapeutic effects of the drug, particularly at sites where the supply of serum-derived factors is limited.

KW - hemodialysate, protein-free

KW - macrophages

KW - monocytes, differentiation, human

KW - Solcoseryl®

KW - wound healing drugs

UR - http://www.scopus.com/inward/record.url?scp=0027240175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027240175&partnerID=8YFLogxK

M3 - Article

C2 - 8369007

AN - SCOPUS:0027240175

VL - 43

SP - 747

EP - 751

JO - Arzneimittel-Forschung/Drug Research

JF - Arzneimittel-Forschung/Drug Research

SN - 0004-4172

IS - 7

ER -